HKSE:2367

Giant Biogene Holding Co., Ltd. · HKSE · Consumer Defensive · HKD · FY for 2025

Figures on this page computed 2026-11-08 13:40 UTC

Last close

n/aHKD

Market data

9.6xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
HKD
- computed
- Computed from the filing for 2025
47.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
34.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
27.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.001Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
6.9%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
HKD
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

All from 100

lens 2 of 9

Sales

577

2019-12-31 to 2025-12-31100 at the start577

Sales: 100.00 on 2019-12-31 to 576.83 on 2025-12-31, up 477%.

Profit

347

2019-12-31 to 2025-12-31100 at the start347

Profit: 100.00 on 2019-12-31 to 346.73 on 2025-12-31, up 247%.

Shares in issue

107

2019-12-31 to 2025-12-31100 at the start107

Shares in issue: 100.00 on 2019-12-31 to 106.83 on 2025-12-31, up 7%.

Sales is at 577, Profit is at 347, Shares in issue is at 107, against 100 in 2019.

Sales is at 577, Profit is at 347, Shares in issue is at 107, against 100 in 2019.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100577
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100347
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100107
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY